|
시장보고서
상품코드
1417696
G단백질 연결 수용체 시장 보고서 : 동향, 예측, 경쟁 분석(-2030년)G Protein Coupled Receptor Market Report: Trends, Forecast and Competitive Analysis to 2030 |
||||||
G단백질 연결 수용체의 동향과 예측
세계의 G단백질 연결 수용체 시장은 2024-2030년의 CAGR이 6.7%로, 2030년까지 추정 87억 달러에 달할 것으로 예상되고 있습니다. 이 시장의 주요 촉진요인은 심혈관질환의 유병률 상승, 혁신적인 의약품 및 치료법 창출을 목표로 한 연구개발에 관련된 비용의 증대, 약물전달 프로세스의 채택 확대 등입니다. 세계의 G단백질 연결 수용체 시장의 미래는 암연구, 중추신경계 연구, 대사 연구, 심혈관연구, 호흡기 연구, 염증 연구 각 시장에서의 기회로 유망시되고 있습니다.
G단백질 연결 수용체 시장 인사이트
Lucintel은 세포주는 다양한 검사에 이용 가능하고, GPCR 표적을 식별하기 위한 세포 임피던스 실험에서는 세포주의 사용이 중요하기 때문에 예측 기간 중에도 최대 부문을 유지할 것으로 예측하고 있습니다.
북미는 암연구에 대한 자금 제공, GPCR 표적약 승인, 연구개발과 Drug Discovery 구상의 중점화에 의해 예측 기간 중에도 최대 지역을 유지할 것으로 생각됩니다.
Q1.시장 규모는?
A1.세계의 G단백질 연결 수용체 시장은 2030년까지 추정 87억 달러에 달할 것으로 예상되고 있습니다.
Q2.시장의 성장 예측은?
A2.세계의 G단백질 연결 수용체 시장은 2024-2030년 CAGR 6.7%로 성장할 것으로 예상되고 있습니다.
Q3.시장의 성장에 영향을 미치는 주요 촉진요인은?
A3.이 시장의 주요 촉진요인은 심혈관질환의 유병률 상승, 혁신적인 의약품 및 치료법 창출을 목표로 한 연구개발에 관련된 비용의 증대, 약물전달 프로세스의 채택 확대입니다.
Q4.시장의 주요 부문은?
A4.세계의 G단백질 연결 수용체 시장의 미래는 암연구, 중추신경계 연구, 대사 연구, 심혈관연구, 호흡기 연구, 염증 연구 각 시장에서의 기회로 유망시되고 있습니다.
Q5.시장의 주요 기업은?
A5.G 단백질 공액 수용체의 주요 기업은 다음과 같습니다.
Q6.향후 최대가 되는 시장 부문은?
A6.Lucintel은 세포주는 검사에 이용할 수 있는 종류가 풍부한 것, GPCR 표적을 식별하기 위한 세포 임피던스 실험에서는 세포주의 사용이 중요한 것으로 인해 예측 기간 중에도 최대 부문을 유지할 것으로 예측하고 있습니다.
Q7.시장에서 향후 5년간 최대가 될 것으로 예상되는 지역은?
A7.북미는 암연구에 대한 자금 제공, GPCR 표적약 승인, 연구개발과 Drug Discovery 구상이 보다 중시되고 있는 것으로 인해 예측 기간 중에도 최대 지역을 유지할 것으로 생각됩니다.
Q8.리포트의 커스터마이즈는 가능한가?
A8.네, Lucintel은 추가 비용 없이 10%의 커스터마이즈를 제공합니다.
G Protein Coupled Receptor Trends and Forecast
The future of the global G protein coupled receptor market looks promising with opportunities in the cancer research, CNS research, metabolic research, cardiovascular research, respiratory research, and inflammation research markets. The global G protein coupled receptor market is expected to reach an estimated $8.7 billion by 2030 with a CAGR of 6.7% from 2024 to 2030. The major drivers for this market are rising prevalence of cardiovascular diseases, growing costs associated with research and development efforts aimed at creating innovative pharmaceutical products and treatment, along with the increasing adoption of drug delivery processes.
A more than 150-page report is developed to help in your business decisions.
G Protein Coupled Receptor by Segment
The study includes a forecast for the global G protein coupled receptor by product, assay type, application, and region.
List of G Protein Coupled Receptor Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies G protein coupled receptor companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the G protein coupled receptor companies profiled in this report include-
G Protein Coupled Receptor Market Insights
Lucintel forecasts that cell lines will remain the largest segment over the forecast period because a wide variety of cell lines are available for the tests, and the use of cell lines is crucial in cellular impedance experiments used to identify GPCR targets.
North America will remain the largest region over the forecast period because of the funds for cancer research, the approving of GPCR-targeted medications, and a stronger emphasis on the region's drug development and discovery initiatives.
Features of the Global G Protein Coupled Receptor Market
Market Size Estimates: G protein coupled receptor market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: G protein coupled receptor market size by product, assay type, application, and region in terms of value ($B).
Regional Analysis: G protein coupled receptor market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different product, assay type, application, and regions for the G protein coupled receptor market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the G protein coupled receptor market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
FAQ
Q1. What is the G protein coupled receptor market size?
Answer: The global G protein coupled receptor market is expected to reach an estimated $8.7 billion by 2030.
Q2. What is the growth forecast for G protein coupled receptor market?
Answer: The global G protein coupled receptor market is expected to grow with a CAGR of 6.7% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the G protein coupled receptor market?
Answer: The major drivers for this market are rising prevalence of cardiovascular diseases, growing costs associated with research and development efforts aimed at creating innovative pharmaceutical products and treatment, along with the increasing adoption of drug delivery processes.
Q4. What are the major segments for G protein coupled receptor market?
Answer: The future of the global G protein coupled receptor market looks promising with opportunities in the cancer research, CNS research, metabolic research, cardiovascular research, respiratory research, and inflammation research markets.
Q5. Who are the key G protein coupled receptor market companies?
Answer: Some of the key G protein coupled receptor companies are as follows.
Q6. Which G protein coupled receptor market segment will be the largest in future?
Answer: Lucintel forecasts that cell lines will remain the largest segment over the forecast period because a wide variety of cell lines are available for the tests, and the use of cell lines is crucial in cellular impedance experiments used to identify GPCR targets.
Q7. In G protein coupled receptor market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period because of the funds for cancer research, the approving of GPCR-targeted medications, and a stronger emphasis on the region's drug development and discovery initiatives.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.